Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05898711 · ClinicalTrials.gov registry record
Kerecis Case Registry for SurgiBind : Soft Tissue Reinforcement
A clinical trial of Surgery--Complications, sponsored by Kerecis.
- Active
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT05898711 is a study of Surgery--Complications that is active but no longer recruiting, run by Kerecis. The registered enrollment target is 200 participants, below the 2,724-participant average among 11 other Surgery--Complications trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05898711, a study of Surgery--Complications, is active but no longer recruiting, sponsored by Kerecis.
- ACTIVE NOT RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
Registry Objectives The overall objective of the registry is to collect quality and safety data to assess the long-term outcomes of Kerecis Omega3 SurgiBind in surgical procedures to reinforce soft tissue and prevent surgical complications. The ultimate goal of the registry is to enhance the quality of care, patient outcomes and establish a resource to facilitate the use of fish skin in preventing surgical wound dehiscence and surgical site infection.
Conditions Studied
Interventions
- DEVICE Fish skin graft
Study Locations (1)
Virginia
- Kerecis - Arlington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2022-01-27 |
| Est. Completion | 2026-01-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05898711
The ClinicalTrials.gov registry entry for NCT05898711 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,724-participant average among 11 other Surgery--Complications trials with a reported enrollment target (93% lower). The listed sponsor is Kerecis, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Surgery--Complications appearing as the primary indexed condition, and to 1 intervention - of which Fish skin graft is the first listed.
NCT05898711 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT05898711 about?
NCT05898711 is a clinical study titled "Kerecis Case Registry for SurgiBind : Soft Tissue Reinforcement". Registry Objectives The overall objective of the registry is to collect quality and safety data to assess the long-term outcomes of Kerecis Omega3 SurgiBind in surgical procedures to reinforce soft tissue and prevent surgical complications. The ultimate goal of the registry is to enhance the quality...
What is the current status of trial NCT05898711?
This trial is currently active not recruiting. The enrollment target is 200 participants. The study started on 2022-01-27. Estimated completion is 2026-01-27.
What conditions does trial NCT05898711 study?
This clinical trial studies the following conditions: Surgery--Complications.
What interventions are being tested in trial NCT05898711?
The interventions under investigation include: Fish skin graft (DEVICE).
Who is sponsoring clinical trial NCT05898711?
This trial is sponsored by Kerecis, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05898711 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Surgery--Complications
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Zinc Oxide Versus Petrolatum Following Skin Surgery
RECRUITING · Early Phase 1
-
Vascular Events In Patients Undergoing Same-day Noncardiac Surgery (VALIANCE) Study
RECRUITING
-
The Role of Wearable Devices in Cardiothoracic Surgery: Predicting and Detecting Early Postoperative Complications
RECRUITING
-
Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial
RECRUITING · NA
-
Prevent Cardiac Surgery Associated AKI Trial
RECRUITING · Phase 2
-
Mitigating Delirium With Fluvoxamine Treatment for Non-Cardiac Surgery
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.